期刊文献+

胱抑素C与尿微量白蛋白在2型糖尿病早期肾损害中的临床应用 被引量:10

The clinical application of cystatinc and urine microalbum in type 2 diabetes of early renal damage
暂未订购
导出
摘要 目的探讨2型糖尿病(T2DM)患者早期肾损害中胱抑素C(CYSC)和尿微量白蛋白(mALB)联合检测的必要性和意义。方法选取118例住院2型糖尿病患者用免疫透射比浊法检测糖化血红蛋白(HBA1c),按照HBA1c的高低分为控制良好组(A组)和控制不良组(B组),选取79例健康体检人群作为对照组,用免疫透射比浊法检测CYSC、同时检测尿mALB、Ucr,并进行相关性分析。结果 1.糖尿病组的血清CYSC和尿mALB/Ucr与对照组相比均有显著性差异,且差异具有统计学意义(P<0.05);2.随着尿mALB/Ucr的增高血清CYSC显著增高(P<0.05),且两者呈正相关。3.在糖尿病组中血清CYSC和尿mALB/Ucr均可能单独升高(P<0.05),其中血清CYSC单独升高82例、尿mALB/Ucr单独升高81例,两者联合检测阳性率为76.27%。结论血清CYSC和尿液mALB/Ucr是诊断糖尿病早期肾损害的灵敏指标,临床上结合血清CYSC和尿液mALB/Ucr发现病人早期肾功能改变,能够提高发现糖尿病早期肾损害的敏感性。 Objective To explore the necessity and significance combined detection serum CYSC and mALB in in the type 2 diabetic patients(T2DM) with early renal damage.Methods 118 cases of type 2 diabetes in hospital according to the discretion of HBA1c into good control group(group A) and poor control group(group B),79 patients healthy check-up crowd as control group,were determined CYSC HBA1c,urine mALB,Ucr,.Results 1.The CYSC and mALB/ Ucr of diabetic group compared with control group are significant difference(P 0.05).2.mALB/Ucr and CYSC in each group with the relevant analysis shows that with the increase of urinary mALB/Ucr serum CYSC significantly increased(P 0.05),both were positively correlated.3.In diabetic group CYSC and mALB/Ucr could all alone increased(P 0.05),Among them CYSC 82 cases,mALB/Ucr 81 cases,combining both tested positie for 76.27%.Conclusion serum CYSC and urine mALB/Ucr is diagnosed with early renal damage with a sensitive index,Through the mALB/Ucr and CYSC found early renal change can improve the sensitivity of early diabetic renal damage
出处 《中国实验诊断学》 北大核心 2011年第10期1666-1668,共3页 Chinese Journal of Laboratory Diagnosis
关键词 2型糖尿病 胱抑素C 尿微量白蛋白 Type 2 diabetes cystatin C urinary albumin
  • 相关文献

参考文献9

二级参考文献20

  • 1傅汉菁,袁申元.胰激肽原酶在糖尿病治疗中的临床应用[J].中国实用内科杂志,2004,24(11):698-700. 被引量:40
  • 2程苏琴,朱美财.尿微量白蛋白在糖尿病肾损伤早期诊断中的价值[J].中华检验医学杂志,2005,28(7):740-741. 被引量:201
  • 3胡汉宁,陈薇,吴业勤,杨桂,常江.二辛可啉法测定脑脊液蛋白的研究[J].武汉医学杂志,1995,19(2):125-126. 被引量:1
  • 4陈国桢.内科学,第2版[M].北京:人民卫生出版社,1987.803.
  • 5[4]Ascic-Buturovic B,Cavaljuga S.Cystatin C as a marker for detection of early renal failure in diabetes type 2 patients.Bosn J Basic Med Sci 2005,5(4):68 ~71
  • 6[5]Xu GW,Yao H,Weng F et al.Study of urinary 8 -hydroxydeoxy guanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.J Pharm biomed Anal 2004,36(1):101 ~4
  • 7[6]Perkins BA,Krolewski AS.Early nephropathy in type 1 diabetes:a new perspective on who will and who will not progress.Curr Diab Rep.2005,5(6):455 ~63
  • 8[7]Casas JP Chua W,Loukogeorgakis S,et al.Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes:systematic review and meta-analysis.Lancet 2005,366(9502):2026 ~ 33
  • 9[9]Sugaru E,NakagaWa T,One-Kishino M,et al.SMP -534 a meliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice.Am J Physiol Renal physiol 2005,8(5):201 ~204
  • 10[10]Schrijvers BF,Flyvbjerg A,Tilton RG,et al.A neutrul izing VEGF antibody Prevents glomerular by pertrophy in a model of obese type 2 diabetes,the zucker diabetic fatty rat.Nephrol Dial Transplant 2005,25 (1):401 ~ 406

共引文献118

同被引文献62

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部